Peptides and Mast Cell Activation: How GLP-1, GLP-2 and VIP Support the Nervous System in MCAS By Reine DuBois, Integrative Naturopath and Clinical Director The Health Lodge Understanding MCAS and Nervous System Involvement Mast Cell Activation Syndrome (MCAS) is a complex inflammatory disorder in which mast cells release excessive histamine and other mediators, causing symptoms that can affect every organ system
Lancet 406 , 22572268 (2025)
Effects of acute sleep loss on leptin, ghrelin, and adiponectin in adults
These reactions stay limited to the injection area and do not affect the rest of the body
Powder forms circulating outside of regulated clinical trials are typically sold as 'research chemicals' and have not undergone the rigorous quality, safety, and stability testing required for medicines approved by the MHRA
For injectable GLP-1 medications currently in use , patients should be aware of common side effects including nausea, vomiting, diarrhea, and decreased appetite, particularly during dose escalation
